Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

A mixed methods study of the impact of consultant overnight working in an English Emergency Department.

Penn ML, Monks T, Pope C, Clancy M.

Emerg Med J. 2019 May;36(5):298-302. doi: 10.1136/emermed-2018-207571. Epub 2018 Aug 9.

2.

A facility location model for analysis of current and future demand for sexual health services.

Meskarian R, Penn ML, Williams S, Monks T.

PLoS One. 2017 Aug 29;12(8):e0183942. doi: 10.1371/journal.pone.0183942. eCollection 2017.

3.

Modelling self-management pathways for people with diabetes in primary care.

Penn ML, Kennedy AP, Vassilev II, Chew-Graham CA, Protheroe J, Rogers A, Monks T.

BMC Fam Pract. 2015 Sep 2;16:112. doi: 10.1186/s12875-015-0325-7.

4.

Modelling of Hampshire Adult Services--gearing up for future demands.

Desai MS, Penn ML, Brailsford S, Chipulu M.

Health Care Manag Sci. 2008 Jun;11(2):167-76.

PMID:
18581823
5.

Mind, medicine, and metaphysics: reflections on the reclamation of the human spirit.

Penn ML, Wilson L.

Am J Psychother. 2003;57(1):18-31.

PMID:
12647566
6.

HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells.

Eckstein DA, Sherman MP, Penn ML, Chin PS, De Noronha CM, Greene WC, Goldsmith MA.

J Exp Med. 2001 Nov 19;194(10):1407-19.

7.

HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues.

Eckstein DA, Penn ML, Korin YD, Scripture-Adams DD, Zack JA, Kreisberg JF, Roederer M, Sherman MP, Chin PS, Goldsmith MA.

Immunity. 2001 Oct;15(4):671-82.

8.

Primary and recombinant HIV type 1 strains resistant to protease inhibitors are pathogenic in mature human lymphoid tissues.

Penn ML, Myers M, Eckstein DA, Liegler TJ, Hayden M, Mammano F, Clavel F, Deeks SG, Grant RM, Goldsmith MA.

AIDS Res Hum Retroviruses. 2001 Apr 10;17(6):517-23.

PMID:
11350665
9.

Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1.

Schramm B, Penn ML, Palacios EH, Grant RM, Kirchhoff F, Goldsmith MA.

J Virol. 2000 Oct;74(20):9594-600.

10.

Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue.

Grivel JC, Penn ML, Eckstein DA, Schramm B, Speck RF, Abbey NW, Herndier B, Margolis L, Goldsmith MA.

J Virol. 2000 Jun;74(11):5347-51.

11.

Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease.

Schramm B, Penn ML, Speck RF, Chan SY, De Clercq E, Schols D, Connor RI, Goldsmith MA.

J Virol. 2000 Jan;74(1):184-92.

12.

A trans-receptor mechanism for infection of CD4-negative cells by human immunodeficiency virus type 1.

Speck RF, Esser U, Penn ML, Eckstein DA, Pulliam L, Chan SY, Goldsmith MA.

Curr Biol. 1999 May 20;9(10):547-50.

13.

CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue.

Penn ML, Grivel JC, Schramm B, Goldsmith MA, Margolis L.

Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):663-8.

14.

Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infection.

Speck RF, Penn ML, Wimmer J, Esser U, Hague BF, Kindt TJ, Atchison RE, Goldsmith MA.

J Virol. 1998 Jul;72(7):5728-34.

Supplemental Content

Support Center